Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

148 trials with published results (26%)

Research Maturity

400 completed trials (70% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.2%

24 terminated out of 573 trials

Success Rate

94.3%

+7.8% vs benchmark

Late-Stage Pipeline

30%

174 trials in Phase 3/4

Results Transparency

37%

148 of 400 completed with results

Key Signals

148 with results94% success24 terminated

Data Visualizations

Phase Distribution

484Total
Not Applicable (234)
Early P 1 (5)
P 1 (23)
P 2 (48)
P 3 (76)
P 4 (98)

Trial Status

Completed400
Unknown76
Recruiting38
Terminated24
Withdrawn13
Active Not Recruiting11

Trial Success Rate

94.3%

Benchmark: 86.5%

Based on 400 completed trials

Clinical Trials (573)

Showing 20 of 20 trials
NCT07640802Not Yet Recruiting

Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy

NCT04631042Recruiting

Developing Brain, Impulsivity and Compulsivity

NCT07001475Phase 1Active Not Recruiting

A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder

NCT00001246Active Not RecruitingPrimary

Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers

NCT07710014Phase 4Not Yet RecruitingPrimary

Evaluation of Foquest in Adults 65 Years and Older With ADHD

NCT06847165Not ApplicableRecruiting

Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure

NCT04278404Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

NCT05608434Phase 1RecruitingPrimary

Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial

NCT07678827Phase 3Not Yet RecruitingPrimary

A Phase 3 Study of Viloxazine ER Capsules in Korean Children and Adolescents With ADHD

NCT05631626Phase 3Completed

Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.

NCT06180681Not ApplicableRecruiting

Enhancing Team Effectiveness for a Collaborative School-based Intervention for ADHD

NCT07665658Not ApplicableRecruitingPrimary

Effectiveness of Neuroplasticity-Targeted Supplements on Neuroinflammatory Markers, ADHD Symptom Severity, and Clinical Scores in Children

NCT07203092Not ApplicableRecruitingPrimary

Effects of Transcranial Photobiomodulation in ADHD

NCT05802680Not ApplicableRecruitingPrimary

Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation

NCT07647900Not ApplicableActive Not RecruitingPrimary

Photography-Based Intervention for Children With Attention Deficit Hyperactivity Disorder

NCT05683756Not ApplicableActive Not Recruiting

Optimizing Attention and Sleep Intervention Study

NCT05588713Not ApplicableCompletedPrimary

A Systematic Study of Assessment of Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT02688959Not ApplicableRecruitingPrimary

Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)

NCT04561713Not ApplicableCompletedPrimary

Virtual Reality and Diagnostic of Attention Deficit Hyperactivity Disorder (ADHD) (PADA1)

NCT05464056Not ApplicableCompletedPrimary

BUILT Family Lifestyle Program for Children With ADHD

Scroll to load more

Research Network

Activity Timeline